Volume for hemp derivatives is low right now. We’ve reported about potential long-term gains for isolate, with increased demand for domestic product resulting from supply chain disruption, particularly in China. In the short term however, doing business has become more difficult, and CBD products will not be immune to an economic contraction. States and municipalities are imposing various levels of restrictions to try and curtail the explosion of COVID-19 cases,…
Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!